Biblio Discovery — Demo Discovery Service

31,912 results

Showing 221–240 · 0.26 seconds · RSS

  1. Journal Article

    Estimating real-world treatment effects in the presence of measurement error and sparse outcome data using propensity score methods

    Jane Burnell; Amitava Banerjee; Gordon Prescott et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionThe real-world treatment effect of a novel treatment can be estimated by analysing routinely collected patient data, in the form of Electronic Health Records (EHR). Any treatment allocation in EHR is not randomised and there may be systematic differences between the treatment groups…

  2. Journal Article

    Epigenetic and mitoepigenetic regulation in cancer and therapeutic perspectives

    Selcen Celik-Uzuner; Ihsan Nalkiran; Ugur Uzuner et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Epigenetic modifications on nuclear and mitochondrial DNA constitute key regulatory layers influencing the transcriptional, metabolic, and phenotypic adaptability of cancer cells. The canonical principles of epigenetic control encompass DNA methylation, histone modification, and non-coding…

  3. Journal Article

    IR-780 improves urination function and complications in rats with partial bladder outlet obstruction by protecting bladder smooth muscle cell mitochondria from oxidative stress

    Feng Pi; Benhuang Yan; Min Jia et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionPartial bladder outlet obstruction (pBOO) is the most common cause of lower urinary tract symptoms (LUTS). Prolonged BOO induces bladder remodeling, which can lead to severe bladder dysfunction and refractory LUTS in some patients, even after obstruction resolution. This condition…

  4. Journal Article

    Nanotechnology-enabled delivery of luteolin: a comprehensive review on multidisease therapeutic applications

    Yutong Li; Hongxuan Chen; Yong Lu et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Luteolin is a natural flavonoid compound widely found in various plants, known for its antioxidant, anti-inflammatory, cardiovascular protective and anti-tumor activities. However, its low bioavailability due to rapid metabolism and low solubility hinders its clinical application. In recent years…

  5. Journal Article

    Prediction of site-specific drug deposition via dry powder inhaler using non-invasive real-time particle emission signal monitoring system

    Sakiko Hatazoe; Daiki Hira; Tetsuri Kondo et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundAccurate evaluation of regional drug deposition within the respiratory tract is essential for optimizing inhalation therapy efficacy and minimizing adverse effects. However, non-invasive, real-time quantitative methods for site-specific drug delivery assessment remain limited.ObjectiveTo…

  6. Journal Article

    Dasatinib and quercetin mitigate radiation-induced lung injury by eliminating senescent cells in a rat model

    Jing Liu; Xue Ren; Hengjiao Wang et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundRadiation-induced lung injury (RILI) is a major dose-limiting toxicity in thoracic radiotherapy, and accumulating evidence implicates radiation-induced cellular senescence in its pathogenesis. This study aimed to investigate whether combination therapy with dasatinib and quercetin (DQ)…

  7. Journal Article

    Acute post-infusion hypokalemia following rituximab therapy in patients with nephrotic syndrome: case series and literature review

    Weidong Huang; Lishi Yu; Lie Jin et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundRituximab has become an important therapeutic option for nephrotic syndrome (NS), and its adverse event profile is generally well characterized. However, reports of acute hypokalemia specifically occurring in the post-infusion period remain rare. We aimed to present and analyze cases of…

  8. Journal Article

    The impact of nutritional, environmental, and lifestyle factors on neurological disorders: therapeutic implications and mechanistic insights

    Dib Chakif; Julien Furrer

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Neurological disorders like Alzheimer’s, Parkinson’s, multiple sclerosis, and primary psychiatric conditions are complex, arising from a mix of genetic and modifiable risks. Growing evidence indicates that nutrition, environment, and lifestyle significantly influence disease development…

  9. Journal Article

    Recent developments in quercetin nanomedicine and applications in osteoarthritis and rheumatoid arthritis therapies

    Yuan Zhu; Hongxuan Chen; Yuanling Yi et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    Quercetin has attracted increasing attention in the research of treatments for rheumatoid arthritis and osteoarthritis due to its excellent anti-inflammatory, antioxidant, and joint-protective effects. However, the bioavailability of quercetin is relatively low, primarily due to its poor…

  10. Journal Article

    Novel roles of SETD2 in tumor metabolism and immunotherapy: a systematic review and meta-analysis

    Chunhui Liu; Lei Lin; Yonggang Fan

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundSET domain-containing 2 (SETD2), the sole histone H3 lysine 36 trimethyltransferase, has emerged as a critical tumor suppressor across multiple cancer types. Recent evidence suggests SETD2 orchestrates complex interactions between metabolic reprogramming and immune evasion in the tumor…

  11. Journal Article

    Machine learning-assisted analysis of serum metabolomics for identifying biomarkers in intrinsic and idiosyncratic drug-induced liver injury

    Xianni Wei; Jinbao Wei; Yuhong Huang et al.

    Frontiers in Pharmacology, Vol. 16 · 2026 · English · DOAJ Scopus

    ObjectiveThis project aims to employ high-performance chemical isotope labeling (HP-CIL) liquid chromatography–mass spectrometry (LC-MS) to conduct a metabolomic study on the mechanisms underlying intrinsic and idiosyncratic drug-induced liver injury (DILI). By comparing the metabolic…

  12. Journal Article

    Evaluating a multifaceted stewardship intervention on proton pump inhibitor utilization: an interrupted time-series analysis of prescribing patterns in a northwest Chinese hospital

    Xiaoling Wang; David J. McIver; Hui Min et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundPromoting the rational use of proton pump inhibitors (PPIs) has become an important aspect in controlling the growth of pharmaceutical expenditures in China. In recent years, the first national guidelines for the clinical application of PPIs and the second batch of the China National Key…

  13. Journal Article

    Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy

    Sikun Wang; Jiang Zhou; Yuanhua Sun

    Frontiers in Pharmacology, Vol. 16 · 2026 · English · DOAJ Scopus

    BackgroundDrug-induced hypersensitivity syndrome (DIHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a rare but potentially life-threatening adverse drug reaction. Clopidogrel induced DHS following percutaneous coronary intervention (PCI) presents a unique…

  14. Journal Article

    Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism

    Shuang Shen; Min Ning; Muhan Li et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundThe purpose of this study was to investigate the effect and mechanism of Sevelamer hydrochloride (Sev) on cholesterol gallstone formation via the intestinal Fxr-Fgf15 signaling pathway in a mouse model.MethodsA cholesterol gallstone mouse model was established. Mice were divided into…

  15. Journal Article

    A comparative study on the efficacy and safety of biosimilar (Rimmyrah) and reference ranibizumab in patients with diabetic macular edema

    Gaixia Zhai; Xiaona Ren; Bing Xu et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    ObjectiveThis study evaluated the efficacy and safety of the biosimilar Rimmyrah versus the reference ranibizumab in patients with diabetic macular edema (DME).MethodsThis retrospective study included 70 patients with DME. They were divided into two groups: 35 patients (35 eyes) received the…

  16. Journal Article

    Efficacy and safety of Salvia miltiorrhiza and ligustrazine injection for heart failure: a systematic review and meta-analysis

    Pingping Huang; Gaocan Ren; Yifei Wang et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    ObjectiveTo systematically evaluate the efficacy and safety of SMLI in patients with HF.Materials and methodsEight electronic databases were systematically searched from inception up to July 2025 to identify randomized controlled trials (RCTs) comparing SMLI combined with conventional treatment…

  17. Journal Article

    Safety of individualized herbal medicine for dysmenorrhea: pharmacovigilance from South Korea’s national pilot

    Minjung Park; Yongjoo Kim; Nan-He Yoon et al.

    Frontiers in Pharmacology, Vol. 17 · 2026 · English · DOAJ Scopus

    BackgroundIn 2020, South Korea’s National Health Insurance (NHI) began reimbursing individually prescribed herbal medicine decoctions (HMDs) for dysmenorrhea, highlighting the need for robust post-coverage safety monitoring using national claims data.ObjectiveTo evaluate the safety of reimbursed…

  18. Journal Article

    Incorporating patient-reported outcome measures into routine paediatric pharmacovigilance: opportunities for safety monitoring with practical use scenarios from paediatric oncology

    Pedro Teodoro; Ricardo M. Fernandes; Inês Ribeiro et al.

    Frontiers in Pharmacology, Vol. 16 · 2026 · English · DOAJ Scopus

    BackgroundTraditional pharmacovigilance systems often fail to capture children’s experiences of adverse events (AEs), particularly subjective symptoms that affect daily functioning and quality of life. Patient-Reported Outcome Measures (PROMs) offer a complementary perspective by enabling direct…

Showing at most 50 pages. Narrow your search with filters for more specific results.